STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and co-produce biosimilars for the U.S. market.
The company will also launch biosimilar Hyrimoz with Novartis' Sandoz from next year at a list price that is more than 80% lower to AbbVie's blockbuster arthritis drug Humira.
Sverige Senaste nytt, Sverige Rubriker
Similar News:Du kan också läsa nyheter som liknar den här som vi har samlat in från andra nyhetskällor.
Källa: SaltWire Network - 🏆 45. / 63 Läs mer »